Health Investment Partners

What Health Investment Partners does

Health Investment Partners (HIP) is a private impact investment fund headquartered in Amsterdam, Netherlands, founded in 2016. HIP targets innovative Dutch healthcare companies in the scaling phase, providing growth capital alongside hands-on strategic, financial, and operational guidance. The fund invests with a stated dual mandate of financial return and sustainable healthcare impact, measured along three axes: prevention, efficiency, and quality. HIP's investment criteria require a strong entrepreneurial team, a healthy business model targeting a proven product at the cusp of accelerated growth, a clear growth plan, and demonstrable sustainable impact.

HIP's portfolio comprises approximately eight disclosed investments spanning diverse healthcare verticals. Notable positions include Xyall (automated tissue dissection for molecular pathology, Series B in 2022 and follow-on in 2026), Somnox (sleep technology targeting 100 million good sleepers by 2030), Dytter (online caregiver-to-organization matching), SMan (healthcare professional mediation), Mantelaar (student-to-elder caregiving), FamilySupporters (integrated multi-domain care), Sananet (e-coaching for chronic disease patients), and QRS (medical device wholesaling). The fund has repeatedly co-invested with strategic partners including BOM (Brabant Development Agency), Sioux Technologies, Capricorn Partners, and Rabobank.

The firm operates with a small seven-person team collectively bringing approximately 90 years of relevant investment and advisory experience across more than 100 transactions. HIP generates returns through capital appreciation, exits, and dividends from portfolio companies; management fee and carried interest structures are not publicly disclosed. The fund's GTM motion is relationship-driven, sourcing deals through its healthcare network, venture partners, inbound inquiries, and direct outreach to Dutch healthcare entrepreneurs, with no reliance on intermediaries.

Name

Health Investment Partners

Legal name

Health Investment Partners

Website

https://healthinvestmentpartners.nl

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Health Investment Partners is a private Amsterdam-based impact investment fund, founded in 2016, that provides growth capital and hands-on guidance to Dutch healthcare scale-ups across medtech, digital health, care platforms, and wellness.

Ownership category

akta.pro rank

Product category

Healthcare Venture Capital

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro industry

PRIMARYFSANAJAI

Healthcare Access & Life Sciences Impact Funds

Financial & Insurance/Private Equity & Venture Capital/Impact / ESG & Sustainable Investment Funds

SECONDARYFSAAALAG

Sustainable Private Markets (Impact PE/VC, Private Credit, Infrastructure)

Financial & Insurance/Asset & Wealth Management/Asset Management — ESG/Sustainable & Impact Investing

Keywords

• Healthcare venture capital
• Growth capital investment
• Impact investing
• Healthcare scale-ups
• Private equity

Headquarters

HQ city

Amsterdam

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Growth capital deployment: HIP invests its own capital and capital from its investors into portfolio companies in exchange for equity. Returns are generated through capital appreciation, exits, and potentially dividends from portfolio companies.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Health Investment Partners is a Dutch impact investment fund that provides growth capital and hands-on guidance to scaling healthcare companies in the Netherlands. HIP invests beyond the startup phase in scale-ups that demonstrate a sustainable impact on prevention, efficiency, or quality in healthcare. In addition to equity capital, HIP offers strategic coaching, financial structuring, network access, and co-developed impact KPIs, with venture partners actively embedded within portfolio companies to support execution.

Product overview

Health Investment Partners (HIP) is an impact investment fund that provides growth capital and hands-on guidance to innovative healthcare companies in the Netherlands. Rather than operating a unified product platform, HIP functions as a financial investment partner, offering capital and operational support to portfolio companies across various healthcare segments including medical devices, digital health platforms, care staffing, and wellness technology.

Differentiator

Problem solved

Functional benefit

Products and services

• Growth Capital Investment

Quantifiable outcome

• Under Sananet's e-coach applications, polyclinic visits and hospital admissions decreased by 40–50% among users.
• +2 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered minor.

• ECFGminorGTM or Marketing Partner · 1 January 2021Dytter engaged ECFG (which specializes in smart capital) as an advisor for its investment round. ECFG introduced Dytter to HIP as a strategic growth partner with relevant sector knowledge.
• Koninklijke AupingminorStrategic or Co-development Partner · 1 January 2020Somnox entered a collaboration with Koninklijke Auping following its Kickstarter crowdfunding campaign, leveraging Auping's distribution and brand in the sleep/sleeping products market.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• GIMV: Belgian-listed PE investor with a dedicated Health & Care platform serving European growth-stage healthcare companies. Comparable as a Benelux-based healthcare PE, though much larger and publicly listed.
• Invest-NL: Dutch national investment institution with mandates to finance Dutch innovations including healthcare. Comparable as a domestic impact investor backing scaling Dutch healthcare ventures, but operating at much larger scale and with policy-driven capital.
• Seventure Partners: France-based VC/PE firm with dedicated healthtech and impact funds (Health for Life Capital). Comparable as a European impact-oriented healthcare investor, though operating at a larger scale and broader geography.

Emerging players

• ECFG (Energy Capital Founders Group): Netherlands-based investment firm providing 'smart capital' for impact-oriented SMEs. Identified as the advisor that introduced Dytter to HIP, comparable as a small Dutch impact investor in the same ecosystem and active in similar deal sourcing.

Direct peers

• Korys: Belgian family office of the Colruyt Group with active impact investment strategy across health, food, and circular economy. Comparable to HIP as a values-driven, long-term Dutch-speaking impact investor with healthcare exposure.
• Forbion: Leading Dutch/European healthcare VC firm investing across biopharma, MedTech, and digital health. Comparable to HIP as a Dutch-rooted healthcare VC, but operating at substantially larger fund sizes and with broader geographic reach.
• LSP (Life Sciences Partners): Amsterdam-based life sciences and healthcare investment firm with multiple funds across venture and public equities. Comparable to HIP as a Dutch healthcare-focused investment manager, though operating at a larger scale and broader life sciences mandate.
• BOM (Brabant Development Agency): Dutch regional development agency providing risk capital to innovative SMEs including healthcare and life sciences. Co-invested with HIP in Xyall, comparable as a Dutch impact-oriented investor backing scaling healthcare ventures with patient capital.
• Capricorn Partners: Belgian/Dutch venture and growth capital firm with dedicated healthcare and sustainability funds (including Capricorn Healthtech Fund II). Capricorn Partners led the €7.6M Xyall round alongside HIP, making it the most direct comparable as a healthcare-focused PE/VC operating in the same geography and sector.
• Holland Capital: Amsterdam-based independent PE firm investing in Dutch growth-stage companies, with healthcare as a core vertical. Comparable to HIP in fund size, regional focus on the Netherlands, and growth-stage healthcare thesis.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/health-investment-partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Health Investment Partners